Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Yoriko Yamashita"'
Autor:
Risa Oda, Katsuhiro Okuda, Yoriko Yamashita, Tadashi Sakane, Tsutomu Tatematsu, Keisuke Yokota, Katsuhiko Endo, Ryoichi Nakanishi
Publikováno v:
Thoracic Cancer, Vol 11, Iss 7, Pp 2036-2039 (2020)
Abstract Several authors have previously reported that patients with pulmonary combined large cell neuroendocrine cancer ( LCNEC) have a poor prognosis and there is no consensus on the treatment strategy for combined LCNEC as well as LCNEC. Here, we
Externí odkaz:
https://doaj.org/article/4270506c606747348178585eff06885d
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222519 (2019)
Productive replication of Epstein-Barr virus (EBV) during the lytic cycle occurs in discrete sites within nuclei, termed replication compartments. We previously proposed that replication compartments consist of two subnuclear domains: "ongoing replic
Externí odkaz:
https://doaj.org/article/d0f86149da554024992b6f542c9a853e
Autor:
Akira Inagaki, Yoriko Yamashita, Yusuke Mori, Erika Takeuchi, Kyosuke Asaoka, Shingo Murakami
Publikováno v:
Case Reports in Otolaryngology, Vol 2019 (2019)
Pilomatricoma is a benign tumor arising from hair follicle matrix cells, presenting as an asymptomatic, firm, slow growing, mobile, superficial skin nodule typically in children. This lesion with an atypical clinical presentation is frequently misdia
Externí odkaz:
https://doaj.org/article/71da761580754aeba5bde168f37afeb2
Autor:
Yoriko Yamashita, Shinya Akatsuka, Kanako Shinjo, Yasushi Yatabe, Hiroharu Kobayashi, Hiroshi Seko, Hiroaki Kajiyama, Fumitaka Kikkawa, Takashi Takahashi, Shinya Toyokuni
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e57724 (2013)
Clear cell adenocarcinoma of the ovary (OCC) is a chemo-resistant tumor with a relatively poor prognosis and is frequently associated with endometriosis. Although it is assumed that oxidative stress plays some role in the malignant transformation of
Externí odkaz:
https://doaj.org/article/14d4501365c0435c9c7cf47b8310f933
Autor:
Shinya Akatsuka, Yoriko Yamashita, Hiroki Ohara, Yu-Ting Liu, Masashi Izumiya, Koichiro Abe, Masako Ochiai, Li Jiang, Hirotaka Nagai, Yasumasa Okazaki, Hideki Murakami, Yoshitaka Sekido, Eri Arai, Yae Kanai, Okio Hino, Takashi Takahashi, Hitoshi Nakagama, Shinya Toyokuni
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43403 (2012)
Iron overload has been associated with carcinogenesis in humans. Intraperitoneal administration of ferric nitrilotriacetate initiates a Fenton reaction in renal proximal tubules of rodents that ultimately leads to a high incidence of renal cell carci
Externí odkaz:
https://doaj.org/article/0e933988699e410f90272c32e7f21515
Autor:
Yasushi Yoshimura, Naoki Harada, Shigeki Yoshiura, Natsumi Kawasaki, Yoriko Yamashita-Kashima, Takaaki Fujimura
Treatment with Z-VAD-FMK did not suppress the combination growth inhibition effect of obinutuzumab plus prednisolone in resistant clones.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3280c80e16c5bedbd7646732494d736
https://doi.org/10.1158/1535-7163.22522104
https://doi.org/10.1158/1535-7163.22522104
Autor:
Yasushi Yoshimura, Naoki Harada, Shigeki Yoshiura, Natsumi Kawasaki, Yoriko Yamashita-Kashima, Takaaki Fujimura
Follicular lymphoma commonly recurs and is difficult to cure. Obinutuzumab is a humanized glycoengineered type II anti-CD20 antibody with a mode of action that includes induction of antibody-dependent cellular cytotoxicity, antibody-dependent cellula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5773773a828a8b9ec037d5a5fc51bcaa
https://doi.org/10.1158/1535-7163.c.6543279
https://doi.org/10.1158/1535-7163.c.6543279
Autor:
Natsumi Kawasaki, Yoriko Yamashita-Kashima, Takaaki Fujimura, Shigeki Yoshiura, Naoki Harada, Osamu Kondoh, Yasushi Yoshimura
Publikováno v:
Molecular Biology Reports. 49:4421-4433
Background Obinutuzumab, a Type II anti-CD20 antibody, is used to treat follicular lymphoma. A major mode of action of obinutuzumab is antibody-dependent cellular cytotoxicity (ADCC). Knowledge of the mechanisms of resistance to obinutuzumab is impor
Publikováno v:
Blood. 140:6006-6007
Autor:
Nobukata Kazawa, Yoriko Yamashita
Publikováno v:
International Journal of Radiology and Diagnostic Imaging. 3:80-86
We encountered a rare case of HLMS.US and plain CT showed ill-defined para-caval hepatic tumor in the caudate lobe. The contrast enhanced CT showed a relatively poorly enhanced tumor with non-enhanced area suggesting necrosis. On MRI, the tumor prese